The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
Open accessAbstract
Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has emerged as an important complication of COVID-19. A systematic review was done to analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in COVID-19 patients described in literature until date. A comprehensive approach is essential for diagnosing COVID-19-associated ITP after excluding several concomitant factors that can cause thrombocytopenia in COVID-19. Majority of ITP cases (71%) were found to be elderly (> 50 years) and 75% cases had moderate-to-severe COVID-19. Three patients (7%) were in the pediatric age group. Reports of ITP in asymptomatic COVID-19 patients (7%) underscore the need for COVID-19 testing in newly diagnosed patients with ITP irrespective of COVID-19 symptoms amid this pandemic. ITP onset occurred in 20% cases 3 weeks after onset of COVID-19 symptoms, with many reports after clinical recovery. SARS-CoV-2-mediated immune thrombocytopenia can be attributed to the underlying immune dysregulation, susceptibility mutations in SOCS 1, and other mechanisms, including molecular mimicry, cryptic antigen expression, and epitope spreading. No bleeding manifestations were reported in 31% cases at diagnosis. Severe life-threatening bleeding was uncommon. One case of mortality was attributed to intracranial hemorrhage. Secondary Evans syndrome was diagnosed in one case. Good initial response to short course of glucocorticoids and intravenous immunoglobulin has been found with the exception of delayed lag response in one case. Thrombopoietin receptor agonist usage as a second-line agent has been noted in few cases for short duration with no adverse events. In the relatively short follow-up period, four relapses of ITP were found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-162503 · Cited by 2,690
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Neunert, C., Terrell, D. R., Arnold, D. M., Buchanan, G., Cines, D. B., Cooper, N., Cuker, A., Despotovic, J. M., George, J. N., Grace, R. F., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000966 · Cited by 1,406
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946
Mechanism of thrombocytopenia in COVID-19 patients
Xu, P., Zhou, Q., & Xu, J. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04019-0 · Cited by 578
Cuker, A., Gimotty, P. A., Crowther, M. A., & Warkentin, T. E. (2012) · Blood · doi:10.1182/blood-2012-07-443051 · Cited by 479
Heparin-induced thrombocytopenia
Arepally, G. M. (2017) · Blood · doi:10.1182/blood-2016-11-709873 · Cited by 442
Platelets and Infection – An Emerging Role of Platelets in Viral Infection
Assinger, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00649 · Cited by 386
Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France
Moulis, G., Palmaro, A., Montastruc, J.-L., Godeau, B., Lapeyre-Mestre, M., & Sailler, L. (2014) · Blood · doi:10.1182/blood-2014-05-578336 · Cited by 351
Neunert, C., Noroozi, N., Norman, G., Buchanan, G. R., Goy, J., Nazi, I., Kelton, J. G., & Arnold, D. M. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12813 · Cited by 338
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Zulfiqar, A.-A., Lorenzo-Villalba, N., Hassler, P., & Andrès, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010472 · Cited by 319
Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia
Arnold, D. M., Nazi, I., Warkentin, T. E., Smith, J. W., Toltl, L. J., George, J. N., & Kelton, J. G. (2013) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2013.05.005 · Cited by 191
Heparin-induced thrombocytopenia
Lee, G. M., & Arepally, G. M. (2013) · Hematology · doi:10.1182/asheducation-2013.1.668 · Cited by 171
Lyons-Weiler, J. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100051 · Cited by 161
COVID‐19‐associated immune thrombocytopenia
Bomhof, G., Mutsaers, P. G. N. J., Leebeek, F. W. G., te Boekhorst, P. A. W., Hofland, J., Croles, F. N., & Jansen, A. J. G. (2020) · British Journal of Haematology · doi:10.1111/bjh.16850 · Cited by 161
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19
Zhang, Y., Zeng, X., Jiao, Y., Li, Z., Liu, Q., Ye, J., & Yang, M. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.008 · Cited by 160
Lee, P. Y., Platt, C. D., Weeks, S., Grace, R. F., Maher, G. M., Gauthier, K., Devana, S., Vitali, S. H., Randolph, A. G., McDonald, D. R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.033 · Cited by 147
Evans syndrome: clinical perspectives, biological insights and treatment modalities
Jaime‐Pérez, J. C., Aguilar-Calderón, P., Salazar‐Cavazos, L., & Gómez‐Almaguer, D. (2018) · Journal of Blood Medicine · doi:10.2147/jbm.s176144 · Cited by 126
Pal, R., Banerjee, M., Yadav, U., & Bhattacharjee, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.015 · Cited by 122
Self-citationPavord, S. R., Thachil, J. V., Hunt, B. J., Murphy, M. F., Lowe, G., Laffan, M., Makris, M., Newland, A. C., Provan, D., Grainger, J. D., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16775 · Cited by 109
Mahévas, M., Moulis, G., Andrès, E., Rivière, É., Garzaro, M., Crickx, É., Guillotin, V., Malphettes, M., Galicier, L., Noël, N., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.17024 · Cited by 97
Crosstalk Between Platelets and Microbial Pathogens
Li, C., Li, J., & Ni, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01962 · Cited by 93
Antiphospholipid syndrome – an update
Linnemann, B. (2018) · VASA · doi:10.1024/0301-1526/a000723 · Cited by 90
Delayed‐phase thrombocytopenia in patients with coronavirus disease 2019 (COVID‐19)
Chen, W., Li, Z., Yang, B., Wang, P., Zhou, Q., Zhang, Z., Zhu, J., Chen, X., Yang, P., & Zhou, H. (2020) · British Journal of Haematology · doi:10.1111/bjh.16885 · Cited by 89
Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art
Porcelijn, L., Huiskes, E., Oldert, G., Schipperus, M. R., Zwaginga, J. J., & de Haas, M. (2018) · British Journal of Haematology · doi:10.1111/bjh.15404 · Cited by 82
Evans syndrome in a patient with COVID‐19
Li, M. M. Q., Nguyen, C. B., Yeung, Z. P., Sanchez, K., Rosen, D., & Bushan, S. (2020) · British Journal of Haematology · doi:10.1111/bjh.16846 · Cited by 70
Selmi, C. F., Ceribelli, A., Generali, E., Scirè, C. A., Alborghetti, F., Colloredo, G., Porrati, L., Achenza, M. I. S., Santis, M. D., Cavaciocchi, F., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.10.007 · Cited by 68
Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2
Tsao, H. S., Chason, H. M., & Fearon, D. M. (2020) · PEDIATRICS · doi:10.1542/peds.2020-1419 · Cited by 65
Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
Hindilerden, F., Hindilerden, İ. Y., Akar, E., & Yaşar, K. K. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.07.005 · Cited by 57
Severe Pediatric COVID-19 Presenting With Respiratory Failure and Severe Thrombocytopenia
Patel, P. A., Chandrakasan, S., Mickells, G. E., Yildirim, I. B., Kao, C. M., & Bennett, C. M. (2020) · PEDIATRICS · doi:10.1542/peds.2020-1437 · Cited by 50
The antiphospholipid syndrome: an update.
Franchini, M. (2006) · PubMed · Cited by 49
Thrombocytopenia as an initial manifestation of COVID‐19; case series and literature review
Ahmed, M. Z., Khakwani, M. Z., Venkatadasari, I., Horgan, C., Giles, H. V., Jobanputra, S., Lokare, A., Ewing, J. C., Paneesha, S., & Murthy, V. (2020) · British Journal of Haematology · doi:10.1111/bjh.16769 · Cited by 37
Coronavirus disease associated immune thrombocytopenia: Causation or correlation?
Pascolini, S., Granito, A., Muratori, L., Lenzi, M., & Muratori, P. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.08.006 · Cited by 35
Boulware, R., & Refaai, M. A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.01.020 · Cited by 31
COVID-19 as a cause of immune thrombocytopenia
Humbert, S., Razanamahery, J., Payet-Revest, C., Bouiller, K., & Chirouze, C. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.05.003 · Cited by 28
COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate
Bhattacharjee, S., Banerjee, M., & Pal, R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1962-z · Cited by 27
Self-citationImmune Thrombocytopenia Purpura Secondary to COVID-19
Bennett, J., Brown, C. D., Rouse, M. J., Hoffmann, M. S., & Ye, Z. (2020) · Cureus · doi:10.7759/cureus.9083 · Cited by 24
Thrombocytopenia in the Course of COVID-19 Infection
Lorenzo-Villalba, N., Zulfiqar, A., Auburtin, M., Schuhmacher, M. H., Meyer, A., Maouche, Y., Keller, O., & Andrès, E. (2020) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2020_001702 · Cited by 21
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
Merli, M., Ageno, W., Sessa, F., Salvini, M., Caramazza, D., Mora, B., Rossi, A., Rovelli, C., Passamonti, F., & Grossi, P. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04130-2 · Cited by 17
Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
Hindilerden, F., Hindilerden, İ. Y., Şenoğlu, S., & Yaşar, K. K. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00404 · Cited by 17
Cautious interpretation of antiphospholipid antibodies in COVID-19
Mehta, S. K., Bhandari, S., & Mehta, S. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.024 · Cited by 9
Cited by
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
Lee, E., Cines, D. B., Gernsheimer, T., Kessler, C., Michel, M., Tarantino, M. D., Semple, J. W., Arnold, D. M., Godeau, B., Lambert, M. P., et al. (2021) · American Journal of Hematology · doi:10.1002/ajh.26132 · Cited by 388
Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection
Ryan, F. J., Hope, C. M., Masavuli, M. G., Lynn, M. A., Mekonnen, Z. A., Yeow, A. E. L., Garcia-Valtanen, P., Al-Delfi, Z., Gummow, J., Ferguson, C., et al. (2022) · BMC Medicine · doi:10.1186/s12916-021-02228-6 · Cited by 274
Rogue antibodies could be driving severe COVID-19
Khamsi, R. (2021) · Nature · doi:10.1038/d41586-021-00149-1 · Cited by 91
Gordon, S. F., Clothier, H. J., Morgan, H., Buttery, J. P., Phuong, L. K., Monagle, P., Chunilal, S., Wood, E. M., Tran, H., Szer, J., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.030 · Cited by 28
Metadata
- Authors
- Bhattacharjee, S., & Banerjee, M.
- Venue
- SN Comprehensive Clinical Medicine
- Published
- 2020-09-19
- Volume
- 2
- Issue
- 11
- Pages
- 2048-2058
- ISSN
- 2523-8973 (ISSN-L)
- OpenAlex
- W3087313970
- Cited by
- 287
- References
- 43
- FWCI
- 15.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.